AP2782A - Association between ferroquine and an artemisininederivative for treating malaria - Google Patents

Association between ferroquine and an artemisininederivative for treating malaria

Info

Publication number
AP2782A
AP2782A AP2007004211A AP2007004211A AP2782A AP 2782 A AP2782 A AP 2782A AP 2007004211 A AP2007004211 A AP 2007004211A AP 2007004211 A AP2007004211 A AP 2007004211A AP 2782 A AP2782 A AP 2782A
Authority
AP
ARIPO
Prior art keywords
artemisininederivative
ferroquine
association
treating malaria
malaria
Prior art date
Application number
AP2007004211A
Other languages
English (en)
Other versions
AP2007004211A0 (en
Inventor
Laurent Fraisse
Daniel Ter-Minassian
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AP2007004211A0 publication Critical patent/AP2007004211A0/xx
Application granted granted Critical
Publication of AP2782A publication Critical patent/AP2782A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AP2007004211A 2005-04-20 2006-04-18 Association between ferroquine and an artemisininederivative for treating malaria AP2782A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0503932A FR2884715B1 (fr) 2005-04-20 2005-04-20 Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme
PCT/FR2006/000842 WO2006111647A1 (fr) 2005-04-20 2006-04-18 Association entre la ferroquine et un derive d’artemisinine pour le traitement du paludisme

Publications (2)

Publication Number Publication Date
AP2007004211A0 AP2007004211A0 (en) 2007-10-31
AP2782A true AP2782A (en) 2013-10-31

Family

ID=35385843

Family Applications (1)

Application Number Title Priority Date Filing Date
AP2007004211A AP2782A (en) 2005-04-20 2006-04-18 Association between ferroquine and an artemisininederivative for treating malaria

Country Status (30)

Country Link
US (1) US20120258945A1 (xx)
EP (1) EP1874293A1 (xx)
JP (1) JP5148478B2 (xx)
KR (1) KR20080009088A (xx)
CN (2) CN101163470A (xx)
AP (1) AP2782A (xx)
AR (1) AR054253A1 (xx)
AU (1) AU2006238506B2 (xx)
BR (1) BRPI0610851A2 (xx)
CA (1) CA2605385A1 (xx)
CR (1) CR9425A (xx)
DO (1) DOP2006000092A (xx)
EA (1) EA012630B1 (xx)
FR (1) FR2884715B1 (xx)
GT (1) GT200600157A (xx)
HN (1) HN2006015130A (xx)
IL (1) IL186048A0 (xx)
MA (1) MA29451B1 (xx)
MX (1) MX2007012645A (xx)
MY (1) MY145581A (xx)
NO (1) NO20075920L (xx)
NZ (1) NZ562117A (xx)
PA (1) PA8669801A1 (xx)
PE (2) PE20110119A1 (xx)
SG (1) SG161270A1 (xx)
TN (1) TNSN07359A1 (xx)
TW (1) TWI387456B (xx)
UA (1) UA96414C2 (xx)
WO (1) WO2006111647A1 (xx)
ZA (1) ZA200708800B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2926993B1 (fr) 2008-02-06 2011-03-11 Sanofi Aventis Association entre un sel de bis-thiazolium ou l'un de ses precurseurs et l'artemisinine ou l'un de ses derives pour le traitement du paludisme
FR2952823B1 (fr) * 2009-10-30 2012-04-20 Sanofi Aventis Utilisation de la ferroquine dans le traitement ou la prevention du paludisme
FR2951945B1 (fr) 2009-11-05 2013-08-09 Sanofi Aventis Composition pharmaceutique
FR2961209B1 (fr) * 2010-06-11 2013-03-01 Sanofi Aventis Procede de synthese de la ferroquine par amination reductrice convergente.
FR2989588A1 (fr) * 2012-04-19 2013-10-25 Centre Nat Rech Scient Composes pour la prevention ou le traitement des infections par des virus de la famille des flaviviridae
CA2928866C (en) 2013-11-08 2021-11-09 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN105250295B (zh) * 2014-07-07 2018-12-25 广州中医药大学科技产业园有限公司 一种联合用药物及其作为免疫调节剂的应用
WO2017015344A1 (en) * 2015-07-20 2017-01-26 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
CN107802755A (zh) * 2017-11-08 2018-03-16 江西龙卿堂科技有限公司 一种具有防蚊防疟作用的青蒿软膏
KR102073961B1 (ko) * 2018-11-16 2020-02-05 (주)프론트바이오 메트포르민 및 페로센계 화합물을 유효성분으로 함유하는 암 예방 또는 치료용 약학적 조성물
BR112022026791A2 (pt) * 2020-07-09 2023-05-02 Ceva Sante Animale Composições veterinárias para prevenção e/ou tratamento de leishmaniose
US20240207251A1 (en) * 2021-04-26 2024-06-27 Min Bo SHIM Pharmaceutical composition containing artesunate or salt thereof and pyronaridine or salt thereof, for antipyresis, anti-inflammatory efficacy, anti-viral efficacy and treatment or prevention of covid-19, and method using same
CN113952360B (zh) * 2021-09-14 2023-03-10 上海交通大学 一种亚铁离子在治疗疟疾的药物中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290959A2 (de) * 1987-05-08 1988-11-17 Hoechst Aktiengesellschaft Arzneimittelkombination zur Prophylaxe und Therapie von Malaria
WO2005023304A2 (en) * 2003-09-04 2005-03-17 Cipla Limited Antimalarial compositions and manufacturing process thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0290959A2 (de) * 1987-05-08 1988-11-17 Hoechst Aktiengesellschaft Arzneimittelkombination zur Prophylaxe und Therapie von Malaria
WO2005023304A2 (en) * 2003-09-04 2005-03-17 Cipla Limited Antimalarial compositions and manufacturing process thereof

Also Published As

Publication number Publication date
CN101163470A (zh) 2008-04-16
SG161270A1 (en) 2010-05-27
BRPI0610851A2 (pt) 2010-08-03
DOP2006000092A (es) 2006-11-15
JP2008536900A (ja) 2008-09-11
AU2006238506B2 (en) 2012-03-01
NO20075920L (no) 2007-11-16
CR9425A (es) 2008-02-20
WO2006111647A1 (fr) 2006-10-26
ZA200708800B (en) 2009-01-28
MY145581A (en) 2012-02-29
AP2007004211A0 (en) 2007-10-31
JP5148478B2 (ja) 2013-02-20
CA2605385A1 (fr) 2006-10-26
NZ562117A (en) 2010-01-29
PE20061314A1 (es) 2006-12-27
KR20080009088A (ko) 2008-01-24
AU2006238506A1 (en) 2006-10-26
AR054253A1 (es) 2007-06-13
GT200600157A (es) 2006-11-07
MX2007012645A (es) 2007-12-13
EP1874293A1 (fr) 2008-01-09
EA012630B1 (ru) 2009-10-30
PA8669801A1 (es) 2006-11-09
PE20110119A1 (es) 2011-03-08
HN2006015130A (es) 2010-08-19
CN102836163A (zh) 2012-12-26
FR2884715B1 (fr) 2007-06-15
TW200716092A (en) 2007-05-01
UA96414C2 (ru) 2011-11-10
MA29451B1 (fr) 2008-05-02
IL186048A0 (en) 2008-02-09
FR2884715A1 (fr) 2006-10-27
EA200702282A1 (ru) 2008-02-28
TWI387456B (zh) 2013-03-01
TNSN07359A1 (en) 2008-12-31
US20120258945A1 (en) 2012-10-11

Similar Documents

Publication Publication Date Title
AP2782A (en) Association between ferroquine and an artemisininederivative for treating malaria
IL228770A0 (en) processes and intermediates
EP1910736A4 (en) BANDWIDTH SAFE LIGHTING OPTICS FOR BACK AND FRONT LUMINAIRES
IL183278A0 (en) Rod-coupling assemblies
HK1100149A1 (en) Systems and methods for adaptive authentication
EP1864785A4 (en) SETEROLITHOGRAPHIEVERFAHREN
GB0504774D0 (en) Method
GB0523969D0 (en) Inductivwe component
GB0503836D0 (en) Method
TWI371797B (en) Metal duplex and method
GB0513821D0 (en) Transformer
HK1095928A1 (en) Secondary side controller and method therefor
GB0502298D0 (en) Well assembly and method
GB0504096D0 (en) Method
GB0504184D0 (en) Method
GB0505756D0 (en) Method
GB0502046D0 (en) Method
GB2424088B (en) Instrument and communications controller for instrument
IL186262A0 (en) Authentication method and authentication unit
GB0503306D0 (en) Authentication method
GB0511807D0 (en) Process and compound
GB0523637D0 (en) Process and compounds
EP1938123A4 (en) SHIELD STRUCTURE AND METHOD
GB0502360D0 (en) Method
GB0500508D0 (en) An interconection arrangement and related assemblies